Derivative spectrophotometric and fluorimetric methods for determination of rofecoxib in tablets and in human plasma in presence of its photo-degradation product

Gastrointestinal Damage Associated with the Use of Nonsteroidal Antiinflammatory Drugs

M C Allison, Allan G. Howatson, Caroline J. Torrance et al. · New England Journal of Medicine · 1992 · 962 citations · Full text

Medicine, Internal Medicine, Pharmacology +11

High-performance liquid chromatographic–tandem mass spectrometric evaluation and determination of stable isotope labeled analogs of rofecoxib in human plasma samples from oral bioavailability studies

C.M. Chavez-Eng, M.L. Constanzer, B.K. Matuszewski · Journal of Chromatography B · 2002 · 80 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Determination of rofecoxib, a cyclooxygenase-2 specific inhibitor, in human plasma using high-performance liquid chromatography with post-column photochemical derivatization and fluorescence detection

Eric Woolf, I. Fu, B.K. Matuszewski · Journal of Chromatography B Biomedical Sciences and Applications · 1999 · 52 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +17

Improved procedure for the the determination of rofecoxib in human plasma involving 96-well solid-phase extraction and fluorescence detection

Catherine Z. Matthews, Eric Woolf, B.K. Matuszewski · Journal of Chromatography A · 2002 · 34 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +9

Selective and rapid liquid chromatography–mass spectrometry method for the quantification of rofecoxib in pharmacokinetic studies with humans

Ulrike Werner, Dierk Werner, Ralf G. Mundkowski et al. · Journal of Chromatography B Biomedical Sciences and Applications · 2001 · 32 citations

Pharmacy, Pharmacokinetics, Pharmacology +8